How long a patient with grade 2 pulmonary heart disease can live cannot be generalized, and active treatment can prolong life. The principle of treatment of pulmonary heart disease is to control infection and control cardiopulmonary failure.
1. Control of infection: respiratory infections are common causes of exacerbation of chronic pulmonary heart disease, should be based on the location of patients with common pathogenic bacteria and their drug sensitivity to antibiotic therapy, such as amoxicillin, cefuroxime, levofloxacin and other oral treatment, if you find the exact pathogenic bacteria, should be based on the results of the sensitivity of the choice of antibiotics.
2. Control of respiratory failure: keep the airway open, improve the ventilation function, reasonable oxygen therapy to correct hypoxia. For respiratory pathogenesis, such as COPD, bronchodilators should be given, such as tiotropium bromide inhaler, budesonide formoterol inhaler.
3. Control heart failure: control the intake, can be appropriate to use diuretics such as spironolactone, torasemide, positive inotropic agents such as digitalis.
Coronary artery disease with the damage of pulmonary function gradually aggravate the condition, most of the prognosis is poor, but after active treatment can prolong life, improve the quality of life of patients. It is recommended that patients seek early medical treatment, actively accept treatment, maintain a good state of mind, do not blindly self-medication.